Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « AffPaysInc.i » - entrée « Medicine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Medical University of Vienna < Medicine < Mie  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]
Ident.Authors (with country if any)Title
002944 (2013) J. J. Kim ; K. S. Na ; T. H. Kim ; D. H. YooTHU0466 Pilot Trial of Tocilizumab for Refractory Patients with Adult Onset Still’s Disease
002962 (2013) Y. Takakuwa ; H. Yamada ; H. Ito ; S. Ooka ; Y. Yamasaki ; H. Nakano ; M. Hiida ; Y. Kurihara [Japon] ; S. OzakiTHU0410 Characterisation of interstitial lung disease associated with adult still’s disease
002968 (2013) M. Yamamoto ; H. Takahashi ; Y. Naishiro ; T. Tabeya ; K. Ishigami ; Y. Shimizu ; H. Yajima ; M. Matsui ; C. Suzuki ; H. Yamamoto ; S. Honda ; T. Abe ; Y. Suzuki ; T. Himi ; K. Imai [Japon] ; Y. ShinomuraTHU0398 Efficacy of rituximab and other immunosuppressants for IgG4-related disease
002978 (2013) E. Della Torre [Italie] ; S. Franchini [Italie] ; E. Baldissera [Italie] ; G. Cavalli ; E. P. Bozzolo [Italie] ; M. G. Sabbadini [Italie]THU0386 Efficacy of long-term treatment with biologic agents in refractory adult onset still’s disease: A single centre experience on 16 patients
002986 (2013) B. Kisacik ; A. M. Onat ; T. Kasifoglu ; Y. Pehlivan ; O. N. Pamuk ; E. Dalkilic ; S. Dönmez ; S. Y. Bilge ; S. Yilmaz ; H. Erdem ; R. Mercan ; M. A. Ozturk ; C. Bes ; M. Soy ; S. Erten ; V. Cobankara ; S. Senel ; F. A. Oner ; H. Direskeneli ; S. Yilmaz ; S. Kul ; G. Y. Cetin [Turquie] ; M. Sayarlioglu [Turquie]THU0361 Paraneoplastic arthritis: A multi-centered experience
002A69 (2013) I. A. Choi ; J.-H. Kim [Corée du Sud] ; Y. M. Kim [Corée du Sud] ; K. H. Kim [Corée du Sud] ; H. W. Kim ; K. Shin ; E. Y. Lee ; E. B. Lee ; Y.-M. Lee [Corée du Sud] ; Y. W. SongTHU0058 Periodontal disease is associated with rheumatoid arthritis (RA) but its severity is not correlated with RA disease activity
002B17 (2013) K. Ebina ; K. Shi ; T. Tomita ; Y. Kunugiza ; M. Hirao ; J. Hashimoto [Japon] ; H. YoshikawaSAT0495 Assessment of Plantar Pressure Distribution During Walking after Forefoot Surgery in Patients with Rheumatoid Arthritis
002B52 (2013) M. Takeno ; H. Ideguchi ; A. Suda ; R. Watanabe ; H. Kikuchi [Japon] ; H. Nagafuchi ; M. Kuwana [Japon] ; K. Saito ; S. Hirohata ; Y. Ishigatsubo [Japon]SAT0159 Clinical Features of Japanese Patients with Vasculo- BehÇEt’S Disease: A Multicenter Study by BehÇEt’S Disease Research Committee, MHLW
002B62 (2013) Y. Yabe [Japon] ; T. Kojima ; A. Kaneko ; Y. Kanayama ; Y. Hirano ; T. Shioura ; K. Saito [Japon] ; N. Asai ; T. Kobayakawa ; N. IshiguroSAT0143 Analysis of Patients Who Obtained Remission by Disease Activity Score After Tocilizumab Treatment But Still had Low Disease Activity by Clinical Disease Activity Index, and Examination of Points for Treatment Intensification
002B72 (2013) S. Saevarsdottir ; L. Stawiarz [Suède] ; C. Turesson [Suède] ; S. LinbladSAT0133 Previous Biological Therapies Influence Drug Survival in Rheumatoid Arthritis Patients Starting Abatacept Treatment 2006-2012.
002B98 (2013) H. Heo ; Y. J. Kim ; B. S. Koo ; M.-W. So ; W. J. Seo ; Y.-G. Kim ; C.-K. Lee ; B. YooSAT0097 Changes In Bone Mineral Density in Patients with Recent-Onset Rheumatoid Arthritis
002C17 (2013) V. A. Adarichev ; M. Ramez ; P. A. Kenny [États-Unis] ; T. S. FordeSAT0045 In inflammatory arthritis, chemokine CCL19/21 expression is regulated by nuclear factor of activated T cells (NFATC4) pathways
002C24 (2013) S. M. Goodman ; B. Johnson ; W.-T. Huang [États-Unis] ; M. P. Figgie [États-Unis] ; M. Alexiades [États-Unis] ; L. A. MandlSAT0020 Rheumatoid Arthritis (RA) Patients Have Similar Excellent Outcomes After Total Knee Replacement Compared with Osteoarthritis (OA) Patients
002C99 (2013) L. Yang [Japon] ; S. Serada [Japon] ; M. Fujimoto [Japon] ; H. Murota ; Y. Kotobuki [Japon] ; S. Kitaba ; T. Naka [Japon] ; I. KatayamaOP0230 Periostin, a novel matricellular protein, is required for cutaneous sclerosis in a mouse model of scleroderma
002D44 (2013) T. Takeuchi [Japon] ; Y. Kaneko [Japon] ; T. Atsumi ; Y. Tanaka ; M. Inoh ; H. Kobayashi [Japon] ; K. Amano ; M. Miyata ; Y. Murakawa ; T. Fujii ; A. Kawakami ; H. Yamanaka ; K. Yamamoto ; N. Miyasaka [Japon] ; T. MimoriOP0040 Adding Tocilizumab or Switching to Tocilizumab Monotherapy in RA Patients with Inadequate Response to Methotrexate: 24-Week Results from a Randomized Controlled Study (Surprise Study)
002E02 (2013) D. Camellino ; S. Morbelli ; F. Paparo [Italie] ; M. Massollo ; G. Sambuceti ; M. Cutolo ; M. A. CimminoFRI0349 Is interspinous bursitis the explanation of cervical and lumbar pain in polymyalgia rheumatica? a study with fdg-pet/ct.
002E98 (2013) A. Södergren ; K. Karp ; K. Boman ; C. Eriksson ; E. Lundström ; T. Smedby ; B. Möller [Suède] ; S. Rantap Dahlqvist ; S. W Llberg-JonssonFRI0134 Progression of subclinical atherosclerosis over five years in patients with early rheumatoid arthritis
002F05 (2013) A. Ihata ; H. Hagiyama ; S. Nagaoka ; J. Obata ; K. Miyachi ; H. Yamada ; S. Hirohata ; N. Koido ; M. Yamasaki ; K. Miyagi ; S. Ohno [Japon] ; D. Kishimoto ; K. Takase ; M. Hama ; R. Yoshimi ; A. Ueda ; M. Takeno ; Y. IshigatsuboFRI0104 Cohort study of infectious disease risk management in RA patients receiving tocilizumab at 48 weeks (ACT4U-study48)
002F08 (2013) A. Nakashima ; Z. Takeshi ; K. Ogane ; K. Yamada ; M. Kawano ; A. Yachie [Japon]FRI0102 The significance of serum iga in rheumatoid arthritis in the era of biologic therapy
002F30 (2013) S. Kaneshiro ; K. Ebina ; M. Hirao [Japon] ; J. Hashimoto [Japon] ; K. Shi ; H. YoshikawaFRI0054 IL-6 negatively regulates osteoblast differentiation through ERK pathway in vitro
003081 (2013) Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. IshiguroAB0591 Analysis of rheumatoid arthritis patients who were treated with abatacept with rapid effectiveness from japanese multicenter registry system of biological therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/AffPaysInc.i -k "Medicine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/AffPaysInc.i  \
                -Sk "Medicine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    AffPaysInc.i
   |clé=    Medicine
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021